Morgan Stanley’s Arbe Robotics ARBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.46K Sell
12,223
-2,966
-20% -$3.08K ﹤0.01% 7031
2025
Q4
$17.9K Buy
15,189
+2,069
+16% +$3.42K ﹤0.01% 6727
2025
Q3
$21.6K Sell
13,120
-34,755
-73% -$50.7K ﹤0.01% 6670
2025
Q2
$85.2K Sell
47,875
-2,411
-5% -$3.44K ﹤0.01% 6191
2025
Q1
$51.8K Sell
50,286
-29,985
-37% -$66.1K ﹤0.01% 6255
2024
Q4
$149K Buy
80,271
+70,251
+701% +$128K ﹤0.01% 5889
2024
Q3
$19.1K Hold
10,020
﹤0.01% 6515
2024
Q2
$19.1K Hold
10,020
﹤0.01% 6476
2024
Q1
$20.9K Sell
10,020
-11,020
-52% -$21.1K ﹤0.01% 6471
2023
Q4
$45.9K Buy
21,040
+21,020
+105,100% +$42.6K ﹤0.01% 6410
2023
Q3
$47 Sell
20
-7,673
-100% -$20.6K ﹤0.01% 7485
2023
Q2
$22.2K Sell
7,693
-98,800
-93% -$246K ﹤0.01% 6535
2023
Q1
$340K Buy
+106,493
New +$428K ﹤0.01% 5462
2022
Q4
Sell
-5
Closed 7890
2022
Q3
$0 Sell
5
-695
-99% -$4.3K ﹤0.01% 7693
2022
Q2
$4K Sell
700
-688
-50% -$4.68K ﹤0.01% 7438
2022
Q1
$10K Buy
+1,388
New +$10.4K ﹤0.01% 7394

Other funds holding ARBE

Morgan Stanley's ARBE Position: Q1 2026 in Review

Morgan Stanley reduced its Arbe Robotics (ARBE) stake by 20% in Q1 2026, selling an estimated $3.08K and leaving 12,223 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #7031.

Morgan Stanley first reported a position in ARBE in Q1 2022 and has held it in 16 quarters since. The position peaked at $340K in Q1 2023. 51 funds tracked by Wall St. Rank hold ARBE as of Q1 2026.

  • Morgan Stanley held 12,223 shares of Arbe Robotics worth $7.46K as of Q1 2026.
  • Morgan Stanley sold 2,966 Arbe Robotics shares in Q1 2026, an estimated $3.08K.
  • Arbe Robotics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7031 holding.
  • Morgan Stanley first reported a position in Arbe Robotics in Q1 2022 and has held it in 16 quarters since.
  • Morgan Stanley's Arbe Robotics position peaked at $340K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Arbe Robotics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.